Ewing sarcoma—diagnosis, treatment, clinical challenges and future perspectives
SK Zöllner, JF Amatruda, S Bauer, S Collaud… - Journal of clinical …, 2021 - mdpi.com
Ewing sarcoma, a highly aggressive bone and soft-tissue cancer, is considered a prime
example of the paradigms of a translocation-positive sarcoma: a genetically rather simple …
example of the paradigms of a translocation-positive sarcoma: a genetically rather simple …
Disialoganglioside GD2 expression in solid tumors and role as a target for cancer therapy
B Nazha, C Inal, TK Owonikoko - Frontiers in Oncology, 2020 - frontiersin.org
Gangliosides are carbohydrate-containing sphingolipids that are widely expressed in
normal tissues, making most subtypes unsuitable as targets for cancer therapy. However …
normal tissues, making most subtypes unsuitable as targets for cancer therapy. However …
[HTML][HTML] Immunotherapy in soft tissue and bone sarcoma: unraveling the barriers to effectiveness
M Panagi, P Pilavaki, A Constantinidou… - Theranostics, 2022 - ncbi.nlm.nih.gov
Sarcomas are uncommon malignancies of mesenchymal origin that can arise throughout the
human lifespan, at any part of the body. Surgery remains the optimal treatment modality …
human lifespan, at any part of the body. Surgery remains the optimal treatment modality …
[HTML][HTML] Immunotherapy for sarcomas: new frontiers and unveiled opportunities
HK Birdi, A Jirovec, S Cortés-Kaplan… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Sarcomas are a rare malignancy of mesenchymal tissues, comprizing a plethora of unique
subtypes, with more than 60 types. The sheer heterogeneity of disease phenotype makes …
subtypes, with more than 60 types. The sheer heterogeneity of disease phenotype makes …
ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma
N Mensali, H Köksal, S Joaquina, P Wernhoff… - Nature …, 2023 - nature.com
Osteosarcoma (OS) remains a dismal malignancy in children and young adults, with poor
outcome for metastatic and recurrent disease. Immunotherapies in OS are not as promising …
outcome for metastatic and recurrent disease. Immunotherapies in OS are not as promising …
The biological role and immunotherapy of gangliosides and GD3 synthase in cancers
S Cao, X Hu, S Ren, Y Wang, Y Shao, K Wu… - Frontiers in Cell and …, 2023 - frontiersin.org
Gangliosides are a large subfamily of glycosphingolipids that broadly exist in the nervous
system and interact with signaling molecules in the lipid rafts. GD3 and GD2 are two types of …
system and interact with signaling molecules in the lipid rafts. GD3 and GD2 are two types of …
Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer
Triple-negative breast cancer (TNBC), defined as loss of estrogen, progesterone, and Her2
receptors, is a subtype of highly aggressive breast cancer with worse prognosis and poor …
receptors, is a subtype of highly aggressive breast cancer with worse prognosis and poor …
Cancer-associated glycosphingolipids as tumor markers and targets for cancer immunotherapy
S Groux-Degroote, P Delannoy - International Journal of Molecular …, 2021 - mdpi.com
Aberrant expression of glycosphingolipids is a hallmark of cancer cells and is associated
with their malignant properties. Disialylated gangliosides GD2 and GD3 are considered as …
with their malignant properties. Disialylated gangliosides GD2 and GD3 are considered as …
cPLA2 blockade attenuates S100A7-mediated breast tumorigenicity by inhibiting the immunosuppressive tumor microenvironment
Background Molecular mechanisms underlying inflammation-associated breast tumor
growth are poorly studied. S100A7, a pro-inflammatory molecule has been shown to …
growth are poorly studied. S100A7, a pro-inflammatory molecule has been shown to …
Adaptive homeostasis and the p53 isoform network
All living organisms have developed processes to sense and address environmental
changes to maintain a stable internal state (homeostasis). When activated, the p53 tumour …
changes to maintain a stable internal state (homeostasis). When activated, the p53 tumour …